 effect heparin coronari arteri patenc thrombolysi tissu plasminogen activ acut myocardi infarct infarct arteri patenc rate minut coronari thrombolysi recombin tissue-typ plasminogen activ rt-pa concurr heparin anticoagul compar contribut heparin efficaci safeti thrombolysi rt-pa unknown pilot studi patient hour onset acut myocardi infarct mean hour standard dose mg rt-pa hour forty-two patient immedi intraven heparin anticoagul intraven bolu u/hour partial thromboplastin time time control patient rt-pa coronari angiographi day hour rt-pa therapi infarct arteri patenc rate anticoagul control patient recurr ischemia infarct patient control patient differ signific mild moder sever bleed group anticoagul patient control group data rt-pa therapi acut myocardi infarct heparin therapi coronari patenc rate day thrombolysi increas incid minor bleed complic